Susquehanna raised the firm’s price target on Lam Research (LRCX) to $385 from $350 and keeps a Positive rating on the shares. The firm said the company’s March quarter results beat expectations, driven by strong execution across Foundry, HBM-related DRAM, NAND, advanced packaging, and CSBG. March quarter revenue of $5.84B was in line with consensus, while EPS of $1.47 beat expectations.
Meet Samuel – Your Personal Investing Prophet
Explore LRCU for 2X leverage on LRCXPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRCX:
- Lam Research price target raised to $290 from $262 at Goldman Sachs
- Lam Research price target raised to $315 from $300 at JPMorgan
- Lam Research price target raised to $275 from $255 at Barclays
- Lam Research: Sustained Buy on Above-Consensus Growth, Market Share Gains, and Multi-Year WFE Upside
- Closing Bell Movers: Tesla reverses post-earnings gains, IBM slips after Q1